What is OnKure Therapeutics, Inc.'s free cash flow yield?

OnKure Therapeutics, Inc. (OKUR) reported free cash flow yield of -28.5% in Q1 2026.

How has OnKure Therapeutics, Inc.'s free cash flow yield changed year-over-year?

OnKure Therapeutics, Inc.'s free cash flow yield increased by 5.0% year-over-year, from -30% to -28.5%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

OnKure Therapeutics, Inc. OKUR Free cash flow yield

Free cash flow yield at other companies

PfizerPFE

7.8%+4.6pp

Inhibrx Biosciences, Inc.INBX

-13.4%-6.1pp

Replimune GroupREPL

-37.2%+152pp

IDEAYA Biosciences, Inc.IDYA

-3%-1.4pp

Erasca, Inc.ERAS

-1.8%-0.9pp

Arcus BiosciencesRCUS

-18.1%—

Other financials

Income statement

See full

Revenue-—

Operating income-$15.6M+8.1%

Net income-$15.2M+4.8%

EPS (diluted)-$1.11+6.7%

Balance sheet

See full

Cash & equivalents$192.1M+98.7%

Total debt$409.0K-57.2%

Total equity$184.4M+103%

Total assets$198.7M+98.9%

Cash flow

See full

Operating cash flow-$12.9M+7.6%

CapEx$5.0K-72.2%

Free cash flow-$12.9M+7.7%

Valuation

See full

Market cap$184.2M+72.6%

Enterprise value-$7.49M-127%

Returns & leverage

See full

Return on equity-42.7%—

Debt / equity0×0.0×

Current ratio13.8×+2.6×

Where this comes from

Calculated from OnKure Therapeutics, Inc.’s reported figures.

free cash flow/market cap=-28.5%

Based on trailing twelve months.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s free cash flow yield?: OnKure Therapeutics, Inc. (OKUR) reported free cash flow yield of -28.5% in Q1 2026.
How has OnKure Therapeutics, Inc.'s free cash flow yield changed year-over-year?: OnKure Therapeutics, Inc.'s free cash flow yield increased by 5.0% year-over-year, from -30% to -28.5%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.